KRT8P34

Across TCGA pan-cancer cohorts, KRT8P34 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated KRT8P34 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher KRT8P34 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated KRT8P34 expression acts as an unfavorable survival marker, although some lineages such as THCA and READ show a favorable association.

THCA, PAAD, and KIRC are the cancer types where KRT8P34 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Median	IV	1.000	0.781	.006	50	view →
PAAD	OS	Tertile	All	0.412	0.646	.001	35	view →
KIRC	OS	Quartile	All	0.756	0.826	.006	28	view →
CHOL	DFS	Median	III,IV	0.127	0.647	.006	21	view →
THYM	OS	Tertile	All	0.817	0.946	.043	18	view →
GBM	DFS	Tertile	All	0.099	0.259	<.001	18	view →
LIHC	OS	Tertile	III,IV	0.287	0.579	.007	18	view →
READ	OS	Median	All	0.966	0.861	.005	17	view →
BLCA	DFS	Median	All	0.679	0.515	.020	12	view →
STAD	DFS	Median	IV	0.157	0.566	.003	12	view →
CESC	DFS	Quartile	III,IV	0.930	0.659	.018	10	view →
LGG	DFS	Tertile	All	0.715	0.836	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

KRT8P34–THCA (DFS)

Open the THCA breakdown →